Exelixis, Inc. Sustainability Profile
Exelixis, Inc., a prominent biotechnology firm headquartered in the United States, has established itself as a leader in the oncology sector since its founding in 1994. With a focus on developing innovative cancer therapies, Exelixis operates primarily in North America and has made significant strides in advancing targeted treatments for various malignancies. The company’s flagship product, cabozantinib, exemplifies its commitment to precision medicine, offering unique mechanisms of action that address complex tumour biology. Exelixis has achieved notable milestones, including successful clinical trials and strategic partnerships, solidifying its position in the competitive biopharmaceutical landscape. With a robust pipeline and a dedication to improving patient outcomes, Exelixis continues to be a key player in the fight against cancer.
DitchCarbon Score
How does Exelixis, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Exelixis, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Exelixis, Inc.'s reported carbon emissions
Exelixis, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Exelixis may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Exelixis's position relative to its peers in terms of climate commitments.
How Carbon Intensive is Exelixis, Inc.'s Industry?
How Carbon Intensive is Exelixis, Inc.'s Location?
Exelixis, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Exelixis, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.